HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION JPMA IP Committee Chair Predicts “Minimum Standard” for Data Protection Period for Drugs
August 5, 2015
-
BUSINESS Kyowa Kirin to Draw Up 5-Year Midterm Plan Focusing on Development of Global Products: President Hanai
August 4, 2015
-
ORGANIZATION “All-Japan” System Needed to Contend with Top Global Drug Makers: JPMA R&D Head
August 3, 2015
-
BUSINESS Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO
July 31, 2015
-
BUSINESS AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug
July 31, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab
July 30, 2015
-
BUSINESS Delving into Securities Filings - 2: Drug Maker Employees Decrease 0.9% in 5 Years
July 30, 2015
-
BUSINESS New AbbVie Japan Chief Says Generics Making Room for Innovation
July 29, 2015
-
BUSINESS Delving into Securities Filings - 1: Average Salary of 25 Makers Up 4.9% in 5 Years, Generic Players Close in on Top-Tier Firms
July 29, 2015
-
ORGANIZATION Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium
July 28, 2015
-
BUSINESS Japan Drug Makers Should Consider Mergers, Other Deals to Survive: Chugai Chief
July 27, 2015
-
BUSINESS Toho to Differentiate Itself through Customer Support Rather than Prices: Pres.
July 24, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with Kenporen Vice President Shirakawa
July 24, 2015
-
REGULATORY Drug Pricing Organization Proposes Re-Pricing of Products with Huge Sales
July 23, 2015
-
REGULATORY Z2 Rule, DPC Incentive Need Revisions in Line with New Generic Target: MOF Budget Examiner
July 22, 2015
-
REGULATORY PAFSC’s First Committee to Discuss Actelion’s Tracleer, Other Products on July 31
July 21, 2015
-
TRENDS IFN-Free Drugs Upending Hepatitis C Market Landscape
July 17, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 3: AZ Set to Harness Rich Pipeline to Pursue Combo Strategy
July 16, 2015
-
BUSINESS As 80% Era Looms, 3 Generic Majors Will Emerge as Dominant Suppliers: Sawai
July 16, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Kenporen Veep Wants Holistic Drug Policy in FY2016 Reform
July 15, 2015
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
